Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study

Affiliations

• ¹ Department of Hematology, University Hospital Doctor Peset, Valencia, Spain.
• ² Department of Hematology, Hospital del Mar, Barcelona, Spain.
• ³ Department of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.
• ⁴ Department of Hematology, Hospital Gregorio Marañón, Madrid, Spain.
• ⁵ Department of Hematology, Hospital de Manises, Valencia, Spain.
• ⁶ Department of Hematology, Hospital Vall d'Hebron, Barcelona, Spain.
• ⁷ Department of Hematology, Hospital Clínico San Carlos, Madrid, Spain.
• ⁸ Department of Hematology, Hospital Virgen del Rocío, Sevilla, Spain.
• ⁹ Department of Hematology, Hospital Francesc Borja, Gandía, Spain.
• ¹⁰ Department of Hematology, Instituto Catalán de Oncología, Girona, Spain.
• ¹¹ Department of Hematology, Hospital La Princesa, Madrid, Spain.
• ¹² Department of Hematology, Hospital Central de Asturias, Oviedo, Spain.
• ¹³ Department of Hematology, Hospital General, Alicante, Spain.
• ¹⁴ Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain.